Clinical, Microbiological and Genetic Factors Associated With Recurrence of Clostridioides Difficile Infection and Development of a Predictive Tool for Recurrence
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Clostridium Difficile Infection
- Sponsor
- Hospital Universitario de Valme
- Enrollment
- 750
- Locations
- 15
- Primary Endpoint
- CDI recurrence
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.
Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.
Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.
Investigators
Nicolás Merchante
Coordinator of the UCEIM-HUV Research Group
Hospital Universitario de Valme
Eligibility Criteria
Inclusion Criteria
- •Age older than 18 years
- •New episode of Clostridioides difficile infection, based on IDSA criteria.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
CDI recurrence
Time Frame: First 8 weeks after end of therapy
Clostridioides difficile recurrence
CDI reinfection
Time Frame: Between 8 weeks after end of therapy and before 24 weeks
New episode of Clostridioides difficile infection
Secondary Outcomes
- Readmission due to CDI infection(During 24 weeks after the end of therapy)